Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KORU Medical Systems, Inc.KRMD · Entity 6517 | Director | October 01, 2026 | October 01, 2026 |
| ViewRay, Inc.VRAY · Entity 111118 | Chief Operating Officer | March 01, 2021 | March 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KORU Medical Systems, Inc.
Report date October 01, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 106,263 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 5,119 · Balance 106,263 |
ViewRay, Inc.
Report date March 01, 2021 · Filed March 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,675,308 |
Reported balance
After 2021-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-03-01 · Tax withholding · Disposed 13,174 · Balance 1,675,308 F1: Payment of tax liability by withholding securities incident to vesting of restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 1,589,687 |
Reported balance
After 2021-03-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-03-02 · Tax withholding · Disposed 85,621 · Balance 1,589,687 F1: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2: Includes 1,504,687 shares granted as RSUs. As of the transaction date, 475,441 of the RSUs have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Payment of tax liability by withholding securities incident to vesting of restricted stock units.
F2: Includes 1,504,687 shares granted as RSUs. As of the transaction date, 475,441 of the RSUs have vested.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SPECTRANETICS CORP
Report date August 09, 2017 · Filed August 11, 2017
Section 16 reporting ended · disclosed 2017-08-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| SPNC Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 1
1 source rowRow 1 · 2017-08-09 · Disposition to issuer · Disposed 133,839 · Balance 0 F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2: Includes 8,572 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.51 · Expires 2018-06-17 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-09 · Disposition to issuer · Disposed 25,000 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.74 · Expires 2018-12-08 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-09 · Disposition to issuer · Disposed 41,245 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.76 · Expires 2020-06-01 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-09 · Disposition to issuer · Disposed 84,794 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.93 · Expires 2021-04-15 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-09 · Disposition to issuer · Disposed 10,937 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.44 · Expires 2023-07-10 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-09 · Disposition to issuer · Disposed 23,870 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.05 · Expires 2026-01-08 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-08-09 · Disposition to issuer · Disposed 80,540 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Righ to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.87 · Expires 2022-05-31 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-09 · Disposition to issuer · Disposed 31,476 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-08-09 · Disposition to issuer · Disposed 1,621 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-08-09 · Disposition to issuer · Disposed 8,436 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-08-09 · Disposition to issuer · Disposed 13,289 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-08-09 · Disposition to issuer · Disposed 18,824 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2017-08-09 · Disposition to issuer · Disposed 35,105 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-08-09 · Disposition to issuer · Disposed 12,550 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes.
F2: Includes 8,572 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes.
F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.
F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerStock Option (Right to Buy) · Derivative | 41,245 | $35.76 Strike: $2.74 | $1,474,921.20 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 3 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,245 shares Expires 2018-12-08 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerStock Option (Right to Buy) · Derivative | 25,000 | $27.99 Strike: $10.51 | $699,750.00 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2018-06-17 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerSPNC Common Stock | 133,839 | $38.50 | $5,152,801.50 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2 · shares: Includes 8,572 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 17:59 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Restricted Stock Unit · Derivative | 2,372 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000120 · wf-form4_149981035701419.xml · derivative · entry 3 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: SPNC Common Stock · 2,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Spectranetics common stock. F4 · derivative.exercise_date: Grant Date: 7/10/2013. Restricted Stock Units are on a 4 year 100% vesting schedule; 25% vested on 7/10/2014; 25% vested on 7/10/2015;and 25% vests each calendar year thereafter. 100% fully vested on 7/10/2017. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 17:59 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Tax withholdingSPNC Common Stock | 1,104 | $38.35 | $42,338.40 |
DisclosureSEC source: 0000789132-17-000120 · wf-form4_149981035701419.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,839 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 17:59 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock | 2,372 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000120 · wf-form4_149981035701419.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted Stock Units granted 7/10/2013; fourth 25% vested 7/10/2017. Read SEC document |
| June 25, 2017 Filed Jun 27, 2017 17:29 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Restricted Stock Unit · Derivative | 1,622 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000114 · wf-form4_149859896687578.xml · derivative · entry 3 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,621 Underlying: SPNC Common Stock · 1,622 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Spectranetics common stock. F4 · derivative.exercise_date: Grant Date: 6/25/2014. Restricted Stock Units are on a 4 year 100% vesting schedule; 25% vested on 6/25/2015; 25% vested on 6/25/2016;and 25% vests each calendar year thereafter. 100% fully vested on 6/25/2018. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| June 25, 2017 Filed Jun 27, 2017 17:29 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Tax withholdingSPNC Common Stock | 755 | $30.90 | $23,329.50 |
DisclosureSEC source: 0000789132-17-000114 · wf-form4_149859896687578.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,571 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document |
| June 25, 2017 Filed Jun 27, 2017 17:29 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock | 1,622 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000114 · wf-form4_149859896687578.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted Stock Units granted 6/25/2014; third 25% vested 6/25/2017. Read SEC document |
| June 11, 2017 Filed Jun 13, 2017 17:32 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Restricted Stock Unit · Derivative | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000103 · wf-form4_149738952161427.xml · derivative · entry 3 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,436 Underlying: SPNC Common Stock · 4,218 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Spectranetics common stock. F4 · derivative.exercise_date: Grant Date: 6/11/2015. Restricted Stock Units are on a 4 year 100% vesting schedule; 25% vest on 6/11/2016; and 25% vests each calendar year thereafter. 100% fully vested on 6/11/2019. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| June 11, 2017 Filed Jun 13, 2017 17:32 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Tax withholdingSPNC Common Stock | 1,964 | $26.35 | $51,751.40 |
DisclosureSEC source: 0000789132-17-000103 · wf-form4_149738952161427.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,704 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document |
| June 11, 2017 Filed Jun 13, 2017 17:32 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000103 · wf-form4_149738952161427.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted Stock Units granted 6/11/2015; second 25% vested 6/11/2017. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 17:47 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock · Derivative | 10,000 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0000789132-17-000055 · wf-form4_148858125425704.xml · derivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: SPNC Common Stock · 10,000 shares Expires 2017-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Grant date 4/17/2007. Options vest over four years with 25% vested on 4/17/2008 and 6.25% vests each calendar quarter thereafter. 100% fully vested on 4/17/2011. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 17:47 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock | 10,000 | $10.90 | $109,000.00 |
DisclosureSEC source: 0000789132-17-000055 · wf-form4_148858125425704.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:47 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock · Derivative | 40,000 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0000789132-17-000053 · wf-form4_148832200113264.xml · derivative · entry 3 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: SPNC Common Stock · 40,000 shares Expires 2017-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Grant date 4/17/2007. Options vest over four years with 25% vested on 4/17/2008 and 6.25% vests each calendar quarter thereafter. 100% fully vested on 4/17/2011. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:47 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | SaleSPNC Common Stock | 19,000 | $27.90 | $530,018.30 |
DisclosureSEC source: 0000789132-17-000053 · wf-form4_148832200113264.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,450 F1 · security: Sold pursuant to Mr. Matin's 10b5-1 plan dated 12/14/2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.85 to $28.10, inclusive. The reporting person undertakes to provide to The Spectranetics Corporation, any security holder of The Spectranetics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:47 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock | 40,000 | $10.90 | $436,000.00 |
DisclosureSEC source: 0000789132-17-000053 · wf-form4_148832200113264.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 17:06 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Tax withholdingSPNC Common Stock | 8,223 | $24.50 | $201,463.50 |
DisclosureSEC source: 0000789132-17-000050 · wf-form4_148797395995336.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,450 F2 · shares: Shares withheld to satisfy tax withholding obligations on 25,715 shares issued in settlement of vested PSUs on February 22, 2017. F3 · balance_after: This number includes 8,572 earned PSUs that are scheduled to vest and be settled in an equal number of Company shares as described above. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 17:06 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | GrantSPNC Common Stock | 34,287 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000050 · wf-form4_148797395995336.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,673 F1 · shares: On June 25, 2014, the Reporting Person was awarded 35,347 target performance stock units ("PSUs") granted for the 2014-2016 performance period. Each earned and vested PSU is payable in one share of the Company's common stock. The Reporting Person earned 34,287 of the PSUs based upon the Company's achievement of certain performance goals during the performance period. Of the 34,287 earned PSUs, 75% vested and were settled in an equal number of shares of the Company's common stock on February 22, 2017, and 25% will vest and be settled in shares on December 31, 2017. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 17:31 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | GrantSPNC Restricted Stock Unit · Derivative | 18,824 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000022 · wf-form4_148477868142714.xml · derivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,824 Underlying: Common Stock · 18,824 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Spectranetics common stock. F2 · derivative.exercise_date: Grant Date: 1/13/2017. RSUs vest 25% on each of the first four anniversaries of the grant date. RSUs are 100% vested on 1/13/2021. F2 · derivative.expiration_date: Grant Date: 1/13/2017. RSUs vest 25% on each of the first four anniversaries of the grant date. RSUs are 100% vested on 1/13/2021. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 17:12 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Restricted Stock Unit · Derivative | 4,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000009 · wf-form4_148408631340908.xml · derivative · entry 3 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,289 Underlying: SPNC Common Stock · 4,430 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Spectranetics common stock. F4 · derivative.exercise_date: Grant Date: 1/8/2016. Restricted Stock Units are on a 4 year 100% vesting schedule; 25% vested on 1/8/2017; 25% vests on 1/8/2018;and 25% vests each calendar year thereafter. 100% fully vested on 1/8/2020. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 17:12 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Tax withholdingSPNC Common Stock | 1,651 | $24.25 | $40,036.75 |
DisclosureSEC source: 0000789132-17-000009 · wf-form4_148408631340908.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,386 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 17:12 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Exercise / conversionSPNC Common Stock | 4,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000009 · wf-form4_148408631340908.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted Stock Units granted 1/8/2016; first 25% vested 1/8/2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.